Monitoring patients on ART within the CCMDD programme and those attending an urban healthcare facility in KwaZulu-Natal.

IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL

South African Family Practice Pub Date : 2024-10-23 DOI:10.4102/safp.v66i1.5972

Sheldon Chetty, Andrew Ross

{"title":"Monitoring patients on ART within the CCMDD programme and those attending an urban healthcare facility in KwaZulu-Natal.","authors":"Sheldon Chetty, Andrew Ross","doi":"10.4102/safp.v66i1.5972","DOIUrl":null,"url":null,"abstract":"Background: South Africa has high number of patients on antiretroviral treatment, necessitating innovative approaches to decongest healthcare facilities. The Central Chronic Medicines Dispensing and Distribution (CCMDD) programme is a national initiative that identifies stable chronic patients for collection at pick-up points away from the health facility. This study aimed to compare patient satisfaction and virological suppression among those who collected medication through the CCMDD programme and routine care.Methods: This descriptive retrospective analytical study was conducted at a community health centre in Pietermaritzburg from 01 January 2018 to 31 December 2018 and included a questionnaire and access to their medical records on the national medicines database. The 117 patients in the routine care and CCMDD programme groups were assessed at baseline and evaluated at 6 months and 12 months, which were the time points for viral load (VL) testing.Results: Of the 234 participants, 34 out of 117 (31.6%) remained in routine care at the 6-month review, and all but 7 patients had transferred to the CCMDD after 12 months. At the end of the study, 7 patients had VLs above 50 copies/mL and continued in routine care, while 97% (n = 27/234) remained virologically suppressed. None of the CCMDD programme patients moved out of the programme.Conclusion: Satisfaction with the CCMDD programme is indicated by the patients' continued VL suppression, highlighting its potential to decongest healthcare facilities and reduce the strain associated with medication collection.Contribution: The findings in this study validate patients being registered onto the CCMDD programme.","PeriodicalId":22040,"journal":{"name":"South African Family Practice","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538391/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African Family Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/safp.v66i1.5972","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: South Africa has high number of patients on antiretroviral treatment, necessitating innovative approaches to decongest healthcare facilities. The Central Chronic Medicines Dispensing and Distribution (CCMDD) programme is a national initiative that identifies stable chronic patients for collection at pick-up points away from the health facility. This study aimed to compare patient satisfaction and virological suppression among those who collected medication through the CCMDD programme and routine care.

Methods: This descriptive retrospective analytical study was conducted at a community health centre in Pietermaritzburg from 01 January 2018 to 31 December 2018 and included a questionnaire and access to their medical records on the national medicines database. The 117 patients in the routine care and CCMDD programme groups were assessed at baseline and evaluated at 6 months and 12 months, which were the time points for viral load (VL) testing.

Results: Of the 234 participants, 34 out of 117 (31.6%) remained in routine care at the 6-month review, and all but 7 patients had transferred to the CCMDD after 12 months. At the end of the study, 7 patients had VLs above 50 copies/mL and continued in routine care, while 97% (n = 27/234) remained virologically suppressed. None of the CCMDD programme patients moved out of the programme.

Conclusion: Satisfaction with the CCMDD programme is indicated by the patients' continued VL suppression, highlighting its potential to decongest healthcare facilities and reduce the strain associated with medication collection.Contribution: The findings in this study validate patients being registered onto the CCMDD programme.

查看原文本刊更多论文

在夸祖鲁-纳塔尔省的一家城市医疗机构中，对接受 CCMDD 计划抗逆转录病毒疗法的患者和就诊患者进行监测。

背景：南非有大量接受抗逆转录病毒治疗的患者，因此有必要采取创新方法来缓解医疗机构的拥挤状况。慢性病药物中央配药和分发（CCMDD）计划是一项全国性的举措，旨在确定稳定的慢性病患者，在医疗机构以外的取药点取药。本研究旨在比较通过 CCMDD 计划和常规护理取药的患者的满意度和病毒抑制情况：这项描述性回顾分析研究于 2018 年 1 月 1 日至 2018 年 12 月 31 日在皮特马里茨堡的一家社区医疗中心进行，包括问卷调查和访问国家药品数据库中的医疗记录。对常规护理组和 CCMDD 计划组的 117 名患者进行了基线评估以及 6 个月和 12 个月的评估，这两个时间点是病毒载量（VL）检测的时间点：结果：在 234 名参与者中，117 人中有 34 人（31.6%）在 6 个月复查时仍在接受常规护理，12 个月后，除 7 名患者外，其余患者均已转入 CCMDD。研究结束时，7 名患者的 VL 超过 50 拷贝/毫升，继续接受常规治疗，而 97% 的患者（n = 27/234）的病毒仍被抑制。没有一名 CCMDD 计划患者退出该计划：结论：患者的 VL 持续得到抑制，说明他们对 CCMDD 项目感到满意，这也凸显了该项目在缓解医疗机构拥挤和减轻取药压力方面的潜力：贡献：本研究的结果证实了患者注册 CCMDD 计划的有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

South African Family Practice MEDICINE, GENERAL & INTERNAL-

CiteScore

1.50

自引率

20.00%

发文量

审稿时长

25 weeks

期刊介绍： South African Family Practice (SAFP) is a peer-reviewed scientific journal, which strives to provide primary care physicians and researchers with a broad range of scholarly work in the disciplines of Family Medicine, Primary Health Care, Rural Medicine, District Health and other related fields. SAFP publishes original research, clinical reviews, and pertinent commentary that advance the knowledge base of these disciplines. The content of SAFP is designed to reflect and support further development of the broad basis of these disciplines through original research and critical review of evidence in important clinical areas; as well as to provide practitioners with continuing professional development material.